Growth Metrics

Theravance Biopharma (TBPH) Net Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Theravance Biopharma 823.54 Mn 428.87 Mn - 63.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.40%
Dec 31, 2025 -350.31%
Sep 30, 2025 128.44%
Jun 30, 2025 431.75%
Mar 31, 2025 -16.42%
Dec 31, 2024 377.26%
Sep 30, 2024 -41.88%
Jun 30, 2024 -5.65%
Mar 31, 2024 47.19%
Dec 31, 2023 -317.93%
Sep 30, 2023 -100.97%
Jun 30, 2023 -185.12%
Mar 31, 2023 -241.66%
Dec 31, 2022 -84.90%
Sep 30, 2022 4,400.00%
Jun 30, 2022 47.61%
Mar 31, 2022 128.92%
Dec 31, 2021 134.25%
Sep 30, 2021 127.98%
Jun 30, 2021 119.80%
Mar 31, 2021 108.20%
Dec 31, 2020 -14.72%
Sep 30, 2020 -26.03%
Jun 30, 2020 -57.86%
Mar 31, 2020 -14.43%
Dec 31, 2019 -30.73%
Sep 30, 2019 1.69%
Jun 30, 2019 2.40%
Mar 31, 2019 -11.51%
Dec 31, 2018 42.26%
Sep 30, 2018 11.13%
Jun 30, 2018 38.42%
Mar 31, 2018 0.36%
Dec 31, 2017 -29.09%
Sep 30, 2017 -96.92%
Jun 30, 2017 -40.36%
Mar 31, 2017 -54.97%
Dec 31, 2016 -50.21%
Sep 30, 2016 28.22%
Jun 30, 2016 0.79%
Mar 31, 2016 0.76%
Dec 31, 2015 30.30%
Sep 30, 2015 13.18%
Jun 30, 2015 18.23%
Mar 31, 2015 29.23%
Dec 31, 2014 -45.89%
Sep 30, 2014 -32.66%
Jun 30, 2014 -49.45%
Mar 31, 2014 -86.54%